The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib-Reference-Cited by-同舟云学术

The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib

Published:2013-05 Issue:5 Volume:45 Page:408-413
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Wörns Marcus A.,Koch Sandra,Niederle Ina M.,Marquardt Jens U.,Nguyen-Tat Marc,Gamstätter Thomas,Schuchmann Marcus,Schulze-Bergkamen Henning,Galle Peter R.,Weinmann Arndt

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. Global cancer statistics;Jemal;CA: A Cancer Journal for Clinicians,2011

2. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection;Alazawi;Alimentary Pharmacology and Therapeutics,2010

3. Hepatocellular carcinoma;Forner;Lancet,2012

4. Sorafenib in advanced hepatocellular carcinoma;Llovet;New England Journal of Medicine,2008

5. Efficacy and safety of sorafenib in patients in the Asia–Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncology,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience;Medical Science Monitor;2021-07-14

2. Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor;Hepatoma Research;2021

3. Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database;Cancer Medicine;2020-06-11

4. Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience;Gastrointestinal Tumors;2019

5. Systemic Treatment for Advanced Hepatocellular Carcinoma;Liver Cancer;2019